Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas

BACKGROUND AND PURPOSE: The interpretation of the radiologic response of bevacizumab-treated patients with recurrent high-grade gliomas represents a unique challenge. Delayed-contrast MR imaging was recently introduced for calculating treatment-response-assessment maps in patients with brain tumors,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:AJNR Am J Neuroradiol
Autori principali: Daniels, D., Guez, D., Last, D., Hoffmann, C., Nass, D., Talianski, A., Tsarfaty, G., Salomon, S., Kanner, A.A., Blumenthal, D.T., Bokstein, F., Harnof, S., Yekutieli, D., Zamir, S., Cohen, Z.R., Zach, L., Mardor, Y.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Neuroradiology 2016
Soggetti:
Adult Brain
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7963779/
https://ncbi.nlm.nih.gov/pubmed/27390321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4866
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi